In conclusion, this current work suggests cimifugin is beneficial for psoriasis-like lesions, which is attributed to its inhibitory effect on oxidative stress and inflammation via inactivating NF-κB/MAPK signaling pathway. Here, NFKB1 is linked to psoriasis.